Executive Summary
This brief covers 5 regulatory enforcement filings from India, with two new entries since the last update. The dominant theme is compliance gaps in SEBI LODR norms, with four out of five filings (Medico Remedies, Novelix Pharmaceuticals, Coal India, and Reliable Data Services) highlighting regulatory penalties or show-cause notices for board composition and governance failures.
Notably, these lapses at Coal India and Reliable Data Services point to systemic issues in independent director appointments, creating a governance risk pattern across both PSUs and private firms. No period-over-period financial comparisons or forward-looking guidance were available in these filings due to their regulatory nature, limiting trend analysis. However, the materiality is moderate: while fines are modest (ranging from ₹47,200 to ₹5.45 lakh), the reputational and oversight concerns for Coal India (a large-cap PSU) and Reliable Data Services are material. No insider activity, capital allocation, or scheduled events were disclosed in this batch. The overall sentiment is predominantly negative, with neutral filings on executive appointments and warrant conversions offering no actionable investment signals.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Company update
Tracking the trend? Catch up on the prior India SEBI Regulatory Enforcement Actions digest from June 02, 2026.
Investment Signals (8)
- Coal India ↓ (BEARISH)▲
The ongoing non-compliance with board composition norms (Regulations 17, 18, 19) at a large-cap PSU highlights structural governance weakness; the company's reliance on Ministry of Coal for appointments creates execution risk and potential for further penalties.
- Reliable Data Services ↓ (NEUTRAL)▲
Governance lapse (8-day delay in independent director appointment) corrected on Feb 14, 2026, but the Board's deferral due to due diligence suggests proactive oversight; fine paid, waiver applied.
- Medico Remedies ↓ (NEUTRAL)▲
Swift payment of ₹56,640 fine and compliance achieved since Feb 18, 2026, indicates operational responsiveness; low materiality.
- Novelix Pharmaceuticals ↓ (NEUTRAL)▲
Promoter group warrant conversion of 9.50 lakh shares diluted voting rights slightly (36.77% to 36.42%) but signals confidence in the company's prospects; no financial metrics disclosed.
- Oil & Natural Gas Corporation ↓ (NEUTRAL)▲
Appointed a highly experienced Director (Finance) with industry awards; no financial impact but strengthens leadership continuity.
- Enforcement Pattern (BEARISH)▲
4/5 filings (80%) relate to governance compliance failures, indicating a broader issue in India Inc. that may prompt more stringent SEBI oversight on board composition.
- Reliable Data Services ↓ (BEARISH)▲
The fine amount (₹47,200) is negligible relative to likely market cap, but the recurrence risk for governance lapses could impact stock liquidity or valuation multiples if investor trust erodes.
- Coal India ↓ (BEARISH)▲
Previous waiver of similar penalties by exchanges sets precedent, but repeated issues could lead to more severe action, such as trading restrictions.
Risk Flags (9)
-
Non-compliance with SEBI LODR provisions on board composition (independent directors, audit committee) for Q4 FY26; fine ₹5.45 lakh; risk of escalated action if not resolved swiftly.
-
Governance lapse for Q3 FY25 despite eventually appointing an independent director on Feb 14, 2026; Board was aware of the issue (deferred due to due diligence) but could have sought interim exemption.
-
Show cause notice for non-compliance with Regulation 6(1) for ~48 days (Jan 1 to Feb 17, 2026); inadvertent reporting delay signals weak internal controls.
-
Promoter warrant conversion increased total diluted shares, marginally reducing promoter voting rights (from 36.77% to 36.42%), though still signaling management confidence.
- Portfolio Concentration of Governance Issues▼
4 out of 5 filings involve enforcement actions—this concentration may indicate systemic compliance weaknesses that could attract broader SEBI scrutiny on listed entities.
-
Dependence on government for board appointments (beyond control) introduces unavoidable regulatory risk; inefficiency in timely appointments may recur.
-
Direct fine is low, but legal and compliance costs (consultants, waiver procedures) could add up; management time diversion is an opportunity cost.
-
A public show-cause notice (SoP) can affect investor perception, especially for smaller-cap companies, despite low fine.
- No Insider Activity or Forward Guidance Available▼
Across all 5 filings, there is zero insider trading data or forward-looking guidance, limiting predictive signals—this data gap itself is a risk for proactive investment decisions.
Opportunities (7)
-
Promoter conversion of warrants into equity (9.50 lakh shares) at a likely predetermined price signals insider confidence; if the conversion price is below current market, it indicates cheap equity for the promoter. [OPPORTUNITY – monitor for price arbitrage]
-
Appointment of seasoned Director (Finance) till 2028 ensures continuity in financial leadership; ONGC's planned capex for oil and gas exploration could benefit from stable CFO decision-making. [OPPORTUNITY – long-term governance improvement]
-
If exchange grants waiver (as done previously), it removes overhang; current fine is minimal for a large-cap, and resolution could be a minor positive catalyst. [OPPORTUNITY – event-driven]
-
Since compliance has been achieved since Feb 18, 2026, the overhang is cleared; the company is now likely fully compliant, potentially reducing risk premium. [OPPORTUNITY - small-cap recovery play]
-
Appointment of independent director (Mrs. Bhoomika Gupta) strengthens board; the company's due diligence process, while causing delay, indicates thoroughness—a positive sign for long-term governance quality. [OPPORTUNITY – governance improvement catalyst]
- Regulatory Trend Play◆
With increasing SEBI focus on board composition, companies with already compliant boards (like ONGC now) may command a governance premium; investors can rotate into compliant names.
-
If the Ministry of Coal appoints independent directors promptly, the stock could see a re-rating as governance risk fades; watch for announcements post the waiver request.
Sector Themes (5)
- Systemic Governance Gaps in Board Composition◆
4/5 filings involve non-compliance with SEBI LODR board composition norms (Regulations 17, 18, 19). This spans PSUs (Coal India) and private companies (Reliable Data, Medico), suggesting a widespread challenge in appointing required number of independent directors. Implication: SEBI may tighten enforcement, increasing compliance costs for all listed firms.
- PSU Governance Inefficiency◆
Coal India's inability to appoint independent directors in a timely manner due to government control highlights a structural risk for PSUs where governance depends on government action. Implication: PSUs may trade at a governance discount relative to private peers.
- Low Materiality, High Frequency of Enforcement◆
Fines range from ₹47,200 to ₹5.45 lakh, which are immaterial relative to company revenues/capital. However, the frequency of such actions (4 in a single batch) signals a broader compliance fatigue. Implication: investors should monitor governance scores as a non-financial risk factor.
- No Financial or Operational Data in Enforcement Filings◆
None of the 5 filings contained period-over-period comparisons, insider trading, capital allocation, or forward guidance. This limits fundamental analysis but underscores that regulatory enforcement actions are backward-looking compliance events.
- Muted Insider Activity and Capital Allocation◆
Zero insider trading transactions or capital allocation decisions were found across all filings, which is atypical. Implication: no management conviction signal available; reliance purely on governance risk assessment.
Watch List (8)
-
Watch for exchange response to penalty waiver request; if granted, it removes near-term risk, but if rejected, it could escalate to further penalties or trade restrictions. Timeline: Imminent.
-
The company must ensure future compliance; any repeat lapse could invite stricter action. Watch quarterly corporate governance reports.
-
After the inadvertent disclosure delay, monitor if the company strengthens disclosure processes; any further lapses could lead to penalties. Next scheduled compliance report due with Q1 FY27 filings.
- ONGC/Leadership Transition Impact👁
Monitor for any strategic changes under new CFO (Anupam Agarwal); his appointment is effective June 3, 2026; watch Q1 FY27 commentary for capital allocation or debt management shifts.
-
9.50 lakh new shares hitting the market; monitor stock liquidity and price action; if conversion price is below market, selling pressure possible. Watch for lock-in expiry dates.
- SEBI Stance on Board Compliance👁
After multiple enforcement actions, watch for any new SEBI circulars or stricter norms on board composition deadlines, especially for PSUs. Could be a sector-wide catalyst.
-
Watch for announcements from Ministry of Coal regarding new independent directors; resolution of this issue could trigger a positive re-rating. No known date yet.
- Portfolio Governance Risk Score Update👁
Investors should reassess governance scores for all portfolio companies with SEBI LODR compliance history; this batch highlights the risk of non-compliance even for large caps.
Filing Analyses
(5)
03-06-2026
ONGC announced the appointment of Shri Anupam Agarwal as Director (Finance) effective June 3, 2026, until his superannuation on July 31, 2028. He brings over 35 years of experience in finance and commercial management within the oil and gas sector, having previously served as Director (Finance) of ONGC Videsh Limited. The filing does not contain any financial results or period-over-period comparisons, so no quantitative performance data is available.
- · Shri Agarwal is a Fellow Member of the Institute of Cost Accountants of India, an Associate Member of the Institute of Company Secretaries of India, and a Chartered Financial Analyst from ICFAI, Hyderabad.
- · He joined ONGC in 1990 as a Finance & Accounts Officer.
- · He was awarded the Best CFO Gold Award 2025 by ASSOCHAM for Excellence in Finance Transformation & Innovation and the CFO – Outstanding Performer Award at the CMA Awards 2024 by ICMAI.
- · During his tenure, ONGC Videsh received the ICAI Silver Award for Excellence in Financial Reporting 2024-25 in the Public Sector Entities category.
- · No relationships between directors were disclosed.
03-06-2026
Medico Remedies Limited received a Show Cause Notice (SoP) from NSE and BSE on May 20, 2026, for alleged non-compliance with Regulation 6(1) of SEBI LODR Regulations for the period January 1 to February 17, 2026. The company paid fines of ₹56,640 (inclusive of GST) to each exchange on May 25, 2026, and has been compliant since February 18, 2026. The disclosure was delayed inadvertently, but no material financial or operational impact is expected.
- · Non-compliance period: January 1, 2026 to February 17, 2026
- · Company has been compliant with Regulation 6(1) since February 18, 2026
- · Disclosure delay was inadvertent; company promises future compliance
03-06-2026
Novelix Pharmaceuticals Limited received disclosures under SEBI Takeover Regulations regarding the allotment of 9,50,000 equity shares on May 29, 2026, to promoter and promoter group entities upon conversion of warrants issued via preferential allotment. The allottees are Srinidhi Fine-Chemicals LLP (8,00,000 shares) and Narahari Belide (1,50,000 shares). Post-allotment, the promoter/promoter group holding in terms of shares carrying voting rights decreased slightly from 36.77% to 36.42% on a diluted basis, while the total diluted share capital increased.
- · The warrants were originally issued through preferential allotment and converted on May 29, 2026.
- · Srinidhi Fine-Chemicals LLP held 29,00,000 warrants before conversion and 21,00,000 warrants after conversion.
- · Narahari Belide held 5,50,000 warrants before conversion and 5,50,000 warrants after conversion (no change).
- · The promoter/promoter group holding (diluted) decreased marginally from 41.08% to 41.08% (no change on a fully diluted basis including warrants).
- · The company was formerly known as Trimurthi Limited.
03-06-2026
Coal India Limited (CIL) received a notice from the National Stock Exchange (NSE) imposing a fine of ₹5,45,160 (inclusive of GST) for non-compliance with SEBI LODR Regulations 2017 (Regulations 17(1), 18(1), 19(1) & 19(2)) for the quarter ended March 31, 2026. The company attributes the non-compliance to factors beyond its control, as board appointments are made by the President of India, and has requested a waiver of the penalty.
- · The fine is for non-compliance with Regulations 17(1), 18(1), 19(1) & 19(2) of SEBI LODR, 2015, which relate to board composition, independent directors, and audit committee requirements.
- · CIL states the non-compliance was not due to its negligence and that it has been following up with the Ministry of Coal for appointment of requisite independent directors.
- · The company has requested a waiver of the penalty, noting that similar waiver requests were favorably considered by exchanges in the past.
- · The order/notice from NSE was received on June 2, 2026.
03-06-2026
Reliable Data Services Limited was fined ₹47,200 (inclusive of 18% GST) by NSE and BSE for non-compliance with Regulation 17(1) of the SEBI Listing Regulations regarding Board composition for the quarter ended December 31, 2025. The Board, at its meeting on May 30, 2026, noted the delay was not wilful but due to due diligence issues in appointing an Independent Director, and confirmed that compliance was achieved on February 14, 2026 with the appointment of Mrs. Bhoomika Aditya Gupta. The company has paid the fine and submitted a waiver application, but the incident highlights a governance lapse that required regulatory intervention.
- · The non-compliance was for the quarter ended December 31, 2025, with 8 days of delay.
- · The Board meeting that discussed the fine was held on May 30, 2026.
- · The company had previously deferred the appointment of an Independent Director at its November 14, 2025 board meeting due to due diligence concerns.
- · Compliance was achieved on February 14, 2026, with the appointment of Mrs. Bhoomika Aditya Gupta.
- · The company has paid the fine and submitted a waiver application to both NSE and BSE.
- · Failure to pay the fine within 15 days of the notice (February 27, 2026) could lead to freezing of promoter shareholding and transfer to Z category (trade-for-trade basis).
- · The fine was levied under SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
- · The company's ISIN is INE375Y01018, NSE Symbol RELIABLE, BSE Scrip Code 544207.
Get daily alerts with 8 investment signals, 9 risk alerts, 7 opportunities and full AI analysis of all 5 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India SEBI Regulatory Enforcement Actions
🇮🇳 More from India
View all →June 04, 2026
India Pre-Market Regulatory Roundup — June 04, 2026
India Pre-Market Regulatory Roundup
June 04, 2026
India Quarterly Results BSE NSE Announcements — June 04, 2026
India Quarterly Results BSE NSE Announcements
June 04, 2026
India Upcoming Corporate Actions BSE NSE — June 04, 2026
India Upcoming Corporate Actions BSE NSE
June 03, 2026
India Upcoming Corporate Actions BSE NSE — June 03, 2026
India Upcoming Corporate Actions BSE NSE